| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |